JBS N.V. (JBS) - Net Assets
Based on the latest financial reports, JBS N.V. (JBS) has net assets worth $52.37 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($248.34 Billion) and total liabilities ($195.97 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check JBS cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $52.37 Billion |
| % of Total Assets | 21.09% |
| Annual Growth Rate | 6.71% |
| 5-Year Change | 9.57% |
| 10-Year Change | 122.7% |
| Growth Volatility | 12.97 |
JBS N.V. - Net Assets Trend (2014–2025)
This chart illustrates how JBS N.V.'s net assets have evolved over time, based on quarterly financial data. Also explore JBS N.V. total assets for the complete picture of this company's asset base.
Annual Net Assets for JBS N.V. (2014–2025)
The table below shows the annual net assets of JBS N.V. from 2014 to 2025. For live valuation and market cap data, see JBS stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $52.37 Billion | +3.97% |
| 2024-12-31 | $50.37 Billion | +7.17% |
| 2023-12-31 | $47.00 Billion | -5.64% |
| 2022-12-31 | $49.81 Billion | +4.21% |
| 2021-12-31 | $47.80 Billion | +9.77% |
| 2020-12-31 | $43.54 Billion | +34.06% |
| 2019-12-31 | $32.48 Billion | +16.23% |
| 2018-12-31 | $27.95 Billion | +6.91% |
| 2017-12-31 | $26.14 Billion | +11.16% |
| 2016-12-31 | $23.52 Billion | -20.61% |
| 2015-12-31 | $29.62 Billion | +15.52% |
| 2014-12-31 | $25.64 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to JBS N.V.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 169.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $11.50 Billion | 24.02% |
| Common Stock | $171.18 Million | 0.36% |
| Other Comprehensive Income | $39.44 Billion | 82.40% |
| Total Equity | $47.87 Billion | 100.00% |
JBS N.V. Competitors by Market Cap
The table below lists competitors of JBS N.V. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NAT.B.GR. SPONS.ADR/1
F:NAG
|
$13.22 Billion |
|
The Siam Commercial Bank Public Company Limited
BK:SCB-R
|
$13.22 Billion |
|
YPF Sociedad Anónima
F:YPF
|
$13.22 Billion |
|
Lynas Rare EARTHS Ltd
AU:LYC
|
$13.22 Billion |
|
Universal Scientific Industrial Shanghai Co Ltd
SHG:601231
|
$13.21 Billion |
|
EDP RENOVAV. ADR /2 EO 5
F:EDW0
|
$13.21 Billion |
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
$13.18 Billion |
|
Okta Inc
NASDAQ:OKTA
|
$13.18 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in JBS N.V.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 44,780,867,000 to 47,866,567,000, a change of 3,085,700,000 (6.9%).
- Net income of 11,096,825,000 contributed positively to equity growth.
- Dividend payments of 8,808,823,000 reduced retained earnings.
- Share repurchases of 3,191,677,000 reduced equity.
- Other comprehensive income increased equity by 36,798,471,000.
- Other factors decreased equity by 32,809,096,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $11.10 Billion | +23.18% |
| Dividends Paid | $8.81 Billion | -18.4% |
| Share Repurchases | $3.19 Billion | -6.67% |
| Other Comprehensive Income | $36.80 Billion | +76.88% |
| Other Changes | $-32.81 Billion | -68.54% |
| Total Change | $- | 6.89% |
Book Value vs Market Value Analysis
This analysis compares JBS N.V.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.36x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.96x to 0.36x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $8.28 | $16.24 | x |
| 2015-12-31 | $9.67 | $16.24 | x |
| 2016-12-31 | $8.19 | $16.24 | x |
| 2017-12-31 | $8.54 | $16.24 | x |
| 2018-12-31 | $9.62 | $16.24 | x |
| 2019-12-31 | $11.12 | $16.24 | x |
| 2020-12-31 | $15.11 | $16.24 | x |
| 2021-12-31 | $17.80 | $16.24 | x |
| 2022-12-31 | $20.56 | $16.24 | x |
| 2023-12-31 | $19.54 | $16.24 | x |
| 2024-12-31 | $20.19 | $16.24 | x |
| 2025-12-31 | $44.80 | $16.24 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently JBS N.V. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 23.18%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.36%
- • Asset Turnover: 1.90x
- • Equity Multiplier: 5.19x
- Recent ROE (23.18%) is above the historical average (15.41%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 8.53% | 1.69% | 1.47x | 3.44x | $-351.47 Million |
| 2015 | 16.55% | 2.85% | 1.33x | 4.37x | $1.84 Billion |
| 2016 | 1.04% | 0.14% | 1.66x | 4.60x | $-2.00 Billion |
| 2017 | 2.20% | 0.33% | 1.50x | 4.48x | $-1.89 Billion |
| 2018 | 0.10% | 0.01% | 1.59x | 4.45x | $-2.54 Billion |
| 2019 | 20.48% | 2.97% | 1.62x | 4.26x | $3.10 Billion |
| 2020 | 11.46% | 1.70% | 1.65x | 4.08x | $586.38 Million |
| 2021 | 48.15% | 5.86% | 1.75x | 4.70x | $16.83 Billion |
| 2022 | 34.20% | 4.13% | 1.85x | 4.49x | $11.22 Billion |
| 2023 | -2.45% | -0.29% | 1.76x | 4.75x | $-5.40 Billion |
| 2024 | 21.47% | 2.31% | 1.65x | 5.63x | $5.14 Billion |
| 2025 | 23.18% | 2.36% | 1.90x | 5.19x | $6.31 Billion |
Industry Comparison
This section compares JBS N.V.'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $1,430,842,680
- Average return on equity (ROE) among peers: -58.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| JBS N.V. (JBS) | $52.37 Billion | 8.53% | 3.74x | $13.22 Billion |
| Above Food Ingredients Inc. Common Stock (ABVE) | $-46.26 Million | 0.00% | 0.00x | $38.47 Million |
| Agape ATP Corporation Common Stock (ATPC) | $5.92 Million | 5.99% | 0.22x | $2.64 Million |
| B&G Foods Inc (BGS) | $92.26 Million | 10.03% | 5.46x | $439.85 Million |
| BranchOut Food Inc. Common Stock (BOF) | $-1.23 Million | 0.00% | 0.00x | $49.87 Million |
| Bellring Brands LLC (BRBR) | $-205.90 Million | 0.00% | 0.00x | $1.25 Billion |
| BRC Inc. (BRCC) | $-149.49 Million | 0.00% | 0.00x | $145.60 Million |
| BRF SA ADR (BRFS) | $14.58 Billion | 5.58% | 1.11x | $5.38 Billion |
| Bridgford Foods Corporation (BRID) | $32.53 Million | -38.26% | 0.60x | $67.62 Million |
| Borealis Foods Inc. (BRLS) | $4.64 Million | -566.46% | 12.96x | $32.41 Million |
| Better Choice Company Inc (BTTR) | $-55.86K | 0.00% | 0.00x | $5.13 Million |
About JBS N.V.
JBS N.V., together with its subsidiaries, engages in the processing of animal proteins, encompassing activities related to beef, pork, lamb, and poultry worldwide. The company is involved in the production and marketing of prepared foods and other related products, as well as operations in leather, collagen, hygiene and beauty products, metal packaging, biodiesel, and other related businesses. It… Read more